Dana-Farber Cancer Institute speakers

21 speakers from Dana-Farber Cancer Institute at B2B trade shows and conferences.

Christopher S. Lathan

Dana-Farber Cancer Institute

3 events
tobacco policycancer disparities

Johnson Ung

Dana-Farber Cancer Institute

3 events
career developmentnetworkingcancer research

Kimberly Stegmaier

Dana-Farber Cancer Institute

2 events
drug developmenttranscription factorssynthetic lethality

Cigall Kadoch

assistant professor of pediatric oncology · Dana-Farber Cancer Institute

2 events
chromatin remodelingSWI/SNF complexescancer epigenetics

Irene Roberts

2 events
neonatal haematology

Sarah Donahue, MPH, NP, AOCNP

Session Moderator

1 event
general medicineoncology

Andrew Aguirre

1 event
synthetic lethalityESCRT pathwaycancer genetics

William G. Kaelin Jr., MD

Sidney Farber Professor of Medicine, Investigator · Dana-Farber Cancer Institute, Howard Hughes Medical Institute

1 event
von Hippel-Lindau diseasetranslational research

Stuart Orkin, MD

Dana-Farber Cancer Institute, Children’s Hospital Boston

1 event
genome manipulationhematology researchtherapy

Elad Sharon, MD, MPH

National Cancer Institute

1 event
immune-related adverse eventscheckpoint inhibitorstoxicity

Rosalind Segal

1 event
curriculum developmentneuroscience traininghigher education

A. Thomas Look

Professor of Pediatrics · Dana-Farber Cancer Institute

1 event
NeuroblastomaImmunotherapyCancer research

Catherine J. Wu, MD

Dana-Farber Cancer Institute

1 event
chronic lymphocytic leukemiaclonal dynamicscancer genomics

Rudolph Hulspas

Dana-Farber Cancer Institute

1 event
cancer researchimmunotherapy

Margaret A. Shipp

Dana Farber Cancer Institute

1 event
DLBCL geneticsprognosistherapy

Baochun zhang

1 event

Catherine Wu, MD

Dana-Farber Cancer Institute

1 event
personalized vaccinesneoantigenscancer immunotherapy

Lynne Brady Wagner

Senior Program Manager, Accessibility Services · Dana-Farber Cancer Institute

1 event
accessibility serviceshealthcare management

Christiana Iyasere

MD, MBA, Senior Director Technology Business Development and Accelerator · Dana-Farber Cancer Institute

1 event
Early diligenceTechnology transferAccelerator

Jacqueline Garcia, MD

Dana Farber Cancer Institute

1 event
newly diagnosedolder patienttreatment

Catherine J. Wu

Co-Chair · Dana-Farber Cancer Institute

1 event
genome editingcellular therapytransplantation